Generic API Portfolio
Various Therapeutic Areas
Key Facts
About Divis Laboratories
Divis Laboratories' mission is to create value for stakeholders by manufacturing high-quality Generic APIs, providing custom synthesis, and supplying nutraceutical ingredients through sustainable leadership in chemistry. Its key achievements include establishing itself as a top-3 global API manufacturer, building a trusted CDMO partnership network with 12 of the top 20 Big Pharma companies for over a decade, and achieving a revenue of ~$1.1 billion in FY 2024-25. The company's strategy is built on a foundation of massive, vertically integrated manufacturing scale, a robust R&D engine with ~700 scientists, and an unwavering commitment to quality and regulatory compliance across its global operations.
View full company profileTherapeutic Areas
Other Various Therapeutic Areas Drugs
| Drug | Company | Phase |
|---|---|---|
| Generic API R&D Pipeline | Divis Laboratories | Development |